Ozempic maker Novo Nordisk is building a new $4 billion facility in the U.S. amid weight loss drug shortagesByMiranda NeubauerUpdatedJune 25, 2024
A pharma stock just spiked 35% on a successful heart drug trialByMiranda NeubauerUpdatedJune 24, 2024
Space debris crashed into their home so now a Florida family is suing NASAByMiranda NeubauerPublishedJune 24, 2024
Starbucks is suddenly discounting coffee left and right to win back inflation-weary consumersByMiranda NeubauerUpdatedJune 21, 2024
Olive Garden owner Darden Restaurants beats profit expectationsByMiranda NeubauerUpdatedJune 20, 2024
Kroger beats earnings expectations and points to rising digital salesByMiranda NeubauerUpdatedJune 20, 2024
Boeing Starliner's return to earth is delayed another four daysByMiranda NeubauerPublishedJune 18, 2024
Dollar Tree was accused of selling lead-tainted products after a recallByMiranda NeubauerUpdatedJune 18, 2024
Elizabeth Warren accuses Federal Reserve chair Jerome Powell of doing the banking industry's biddingByMiranda NeubauerUpdatedJune 18, 2024
YouTube will test letting users add notes to videos for contextByMiranda NeubauerPublishedJune 17, 2024
The surgeon general wants social media to come with warning labelsByMiranda NeubauerUpdatedJune 17, 2024
